247 related articles for article (PubMed ID: 21210175)
1. Multicenter surveillance of adult atypical pneumonia in Japan: its clinical features, and efficacy and safety of clarithromycin.
Goto H
J Infect Chemother; 2011 Feb; 17(1):97-104. PubMed ID: 21210175
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: postmarketing surveillance in Japan.
Izumikawa K; Watanabe A; Miyashita N; Ishida T; Hosono H; Kushimoto S; Kohno S
J Infect Chemother; 2014 Sep; 20(9):541-8. PubMed ID: 24934886
[TBL] [Abstract][Full Text] [Related]
3. Prospective surveillance for atypical pathogens in children with community-acquired pneumonia in Japan.
Bamba M; Jozaki K; Sugaya N; Tamai S; Ishihara J; Kori T; Shiro H; Takeuchi Y; Cho H; Nakao A; Okano Y; Kimura K; Komiyama O; Nonoyama M; Kobayashi I; Kato T; Sunakawa K
J Infect Chemother; 2006 Feb; 12(1):36-41. PubMed ID: 16506088
[TBL] [Abstract][Full Text] [Related]
4. [Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult].
Kubo T; Takigawa N; Tanimoto Y; Ichihara E; Tabata M; Miyahara N; Kanehiro A; Kiura K; Tanimoto M
Nihon Kokyuki Gakkai Zasshi; 2007 Oct; 45(10):808-11. PubMed ID: 18018632
[TBL] [Abstract][Full Text] [Related]
5. Mycoplasma and Chlamydia pneumonia in pediatrics.
Nelson CT
Semin Respir Infect; 2002 Mar; 17(1):10-4. PubMed ID: 11891514
[TBL] [Abstract][Full Text] [Related]
6. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
Ouchi K
Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
[TBL] [Abstract][Full Text] [Related]
7. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
[TBL] [Abstract][Full Text] [Related]
8. Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.
Meloni F; Paschetto E; Mangiarotti P; Crepaldi M; Morosini M; Bulgheroni A; Fietta A
J Chemother; 2004 Feb; 16(1):70-6. PubMed ID: 15078002
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial therapy in community-acquired pneumonia among emergency patients in a university hospital in Japan.
Kawai S; Ochi M; Nakagawa T; Goto H
J Infect Chemother; 2004 Dec; 10(6):352-8. PubMed ID: 15614461
[TBL] [Abstract][Full Text] [Related]
10. Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand.
Lochindarat S; Suwanjutha S; Prapphal N; Chantarojanasiri T; Bunnag T; Deerojanawong J; Kunakorn M; Srisan P
Int J Tuberc Lung Dis; 2007 Jul; 11(7):814-9. PubMed ID: 17609060
[TBL] [Abstract][Full Text] [Related]
11. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.
Block S; Hedrick J; Hammerschlag MR; Cassell GH; Craft JC
Pediatr Infect Dis J; 1995 Jun; 14(6):471-7. PubMed ID: 7667050
[TBL] [Abstract][Full Text] [Related]
12. Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
File TM; Eckburg PB; Talbot GH; Llorens L; Friedland HD
Int J Antimicrob Agents; 2017 Aug; 50(2):247-251. PubMed ID: 28599867
[TBL] [Abstract][Full Text] [Related]
13. Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents.
Baer G; Engelcke G; Abele-Horn M; Schaad UB; Heininger U
Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):742-5. PubMed ID: 14610659
[TBL] [Abstract][Full Text] [Related]
14. The role of atypical pathogens in community-acquired pneumonia.
Gupta SK; Sarosi GA
Med Clin North Am; 2001 Nov; 85(6):1349-65, vii. PubMed ID: 11680106
[TBL] [Abstract][Full Text] [Related]
15. Serological Analysis and Drug Resistance of
Du D; Liao S; Wu Y; Jiao Y; Wu D; Wu W; Yu D
Biomed Res Int; 2017; 2017():3120138. PubMed ID: 29057257
[TBL] [Abstract][Full Text] [Related]
16. Analysis of children with Chlamydophila (Chlamydia) pneumoniae and Mycoplasma pneumoniae respiratoryinfections by real-time PCR assay and serological tests.
Otomo S; Yamamura J; Hayashi E; Nakamura T; Kakinuma H; Nakamoto Y; Takahashi H; Karasawa T
APMIS; 2008 Jun; 116(6):477-83. PubMed ID: 18754321
[TBL] [Abstract][Full Text] [Related]
17. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?
Johnston SL; Martin RJ
Am J Respir Crit Care Med; 2005 Nov; 172(9):1078-89. PubMed ID: 15961690
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of severe pneumonia caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-year, population-based surveillance for severe pneumonia in Thailand.
Phares CR; Wangroongsarb P; Chantra S; Paveenkitiporn W; Tondella ML; Benson RF; Thacker WL; Fields BS; Moore MR; Fischer J; Dowell SF; Olsen SJ
Clin Infect Dis; 2007 Dec; 45(12):e147-55. PubMed ID: 18190309
[TBL] [Abstract][Full Text] [Related]
19. Serological study of Bordetella Pertussis, Mycoplasma Pneumonia and Chlamydia Pneumonia in Iranian hajj pilgrims with prolonged cough illnesses: A follow-up study.
Rahimian M; HosseiniB M
Respir Med; 2017 Nov; 132():122-131. PubMed ID: 29229084
[TBL] [Abstract][Full Text] [Related]
20. Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.
Gaillat J; Flahault A; deBarbeyrac B; Orfila J; Portier H; Ducroix JP; Bébéar C; Mayaud C
Eur J Epidemiol; 2005; 20(7):643-51. PubMed ID: 16119439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
